New Blood Biomarker Predicts Alzheimer's in Cognitively Healthy Elderly

Researchers previously thought toxic amyloid accumulation in the brain was the sole contributing factor.

Pexels Matthias Zomer 339620
Matthias Zomer

Determining who will develop Alzheimer’s disease and who won’t is surprisingly nuanced. Previously, scientists believed that amyloid plaques were the main cause of Alzheimer's, leading to drug development focused on targeting them. However, a recent EurekAlert! article suggests that other factors, such as brain inflammation and astrocyte activity, play a significant role in disease progression. Astrocytes are star-shaped cells in the brain that support neurons, and the researchers found that they act as key regulators in Alzheimer's progression.

Sustainable Healthcare Packaging Solutions That Work
Industry leaders share proven strategies for reducing packaging emissions by up to 70% while meeting safety and regulatory requirements.
Read More
Sustainable Healthcare Packaging Solutions That Work
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO